- TSX Venture
- Consumer Products
- Latest 0.265
- Currency C$
- Change 0.0000
- Percent Change 0.00 %
- Volume 0
- Tue Dec 3, 2013 03:20 PM EST TSX Venture data delayed 15 minutes.
12 months ended May 31, 2011.
Trailing 12 month results shown above.
All data is in Canadian dollars.
|Earnings||Oct 30||n/a||Jan 27||n/a|
12 months ended Dec 08, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
WELICHEM BIOTECH INC. is engaged in the discovery and development of novel small molecule therapeutics. Using its Symbiochem technology platform, the Company has developed a robust pipeline of patent-protected compounds that target autoimmune/inflammatory diseases and cancers.
Head Office316 - 4475 Wayburne Drive